scispace - formally typeset
S

Sai Kiang Lim

Researcher at Agency for Science, Technology and Research

Publications -  167
Citations -  24991

Sai Kiang Lim is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Mesenchymal stem cell & Microvesicles. The author has an hindex of 52, co-authored 152 publications receiving 18269 citations. Previous affiliations of Sai Kiang Lim include Genome Institute of Singapore & National University of Singapore.

Papers
More filters
Journal ArticleDOI

Human Embryonic Mesenchymal Stem Cell-Derived Conditioned Medium Rescues Kidney Function in Rats with Established Chronic Kidney Disease

TL;DR: It is demonstrated that administration of MSC-CM has a long-lasting therapeutic rescue function shown by decreased progression of CKD and reduced hypertension and glomerular injury.
Journal ArticleDOI

Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane

TL;DR: It is demonstrated that MSC exosomes are derived from endocytosed lipid rafts and that their protein cargo includes exosome-associated proteins CD81, CD9, Alix and Tsg101.
Journal ArticleDOI

Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration.

TL;DR: It is suggested that MSC exosome is a viable ready-to-use and cell-free MSC therapeutic for the treatment of periodontal defects and demonstrated for the first time that M SC exosomes enhance periodontAL regeneration possibly by increasing PDL migration and proliferation.
Journal ArticleDOI

Haptoglobin, an inflammation-inducible plasma protein.

TL;DR: The current hypothesis is that Hp exerts an anti-inflammatory activity and that by the degree with which Hp attenuates the inflammatory process, including the production of IL-6 cytokines, it determines the level and duration of acute phase expression of the Hp gene.
Journal ArticleDOI

Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway.

TL;DR: MSC exosome enhanced Treg production in vitro and in vivo through an APC-mediated pathway and alleviated GVHD symptoms and increased survival in mice treated with Etanercept.